Digital Therapeutics

Global Market Trajectory & Analytics

MCP11567

EXECUTIVE ENGAGEMENTS

POOL

6337
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1014
Interactions with Platform & by Email

PARTICIPANTS

192
Unique # Participated

VALIDATIONS

41
Responses Validated*

COMPANIES

56
Responses Validated*
* Login for a full stack data experience

DATE

MAY 2021

TABLES

60

PAGES

205

EDITION

7

PRICE

USD 4950

CODE

MCP11567


COMPETITIVE METRICS

COMPANY

D S N T

% *

2Morrow, Inc.

Adherium (NZ) Limited

Akili Interactive Labs, Inc.

Amiko Digital Health Limited

AppliedVR, Inc.

Big Health

Blue Mesa Health

Canary Health Inc.

Chrono Therapeutics

Click Therapeutics, Inc.

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Global Digital Therapeutics Market to Reach $835.8 Million by 2024

Digital therapeutics (DTx), an emerging trend in the rapidly growing mobile health (mHealth) space comprises software programs that blend medical intervention with digital platforms for treatment of medical disorder or conditions. Digital therapeutics enables improved health monitoring, prevention and management leading to improved health outcomes and reduced healthcare expenditure. With rising penetration of smartphones and internet usage, digital therapeutics can offer basic medical guidance, work in combination with drug regimens, use cognitive stimulation to induce behavioural changes, connect with wearables and medical equipment through the use of mobile apps. Amid the COVID-19 crisis, the global market for Digital Therapeutics is projected to reach US$835.8 Million by 2024, registering a compounded annual growth rate (CAGR) of 26.9% over the analysis period. United States represents the largest regional market for Digital Therapeutics, accounting for an estimated 65.1% share of the global total. The market is projected to reach US$708.8 Million by the close of the analysis period. United States is also forecast to emerge as the fastest growing regional market with a CAGR of 27.8% over the analysis period.

Rising incidences of chronic diseases, growing geriatric population, technological advancements, benefits of digital therapeutics, and pressing need to curb rising healthcare costs are key growth drivers spurring significant growth in global digital therapeutics market. Growth in the global market is set to be driven by strong adoption of digital platforms like smartphones, apps, electronic wearables, mobile internet; growing focus on value based care; and rising venture capital investments in digital health based business models. Proliferation of telemedicine platforms and digital healthcare tools such as mobile apps and wearables, has laid a strong foundation for evolution and growth of DTx. The momentum is likely to accelerate further with advent of next-generation technologies such as IoT and Artificial Intelligence (AI), as these `high-tech` modalities hold immense potential to augment roll out of DTx interventions as a complementary product or as a complete replacement to traditional therapeutics. The United States and Europe represent key markets, led supported by well-developed digital infrastructure that provides the foundation for DTx. In Asia-Pacific region, growth is driven by rising prevalence of chronic illnesses and growing geriatric population.

The market for preventive application is forecast to grow the fastest over the analysis period, due to rising government initiatives to enhance preventive healthcare. Government-sponsored programs are mainly intended to encourage healthy lifestyle through broad-based self-management and patient education campaigns. Despite holding immense potential, DTx market suffers from limitations such as resistance from conventional healthcare providers, low awareness levels, patient reluctance to adopt digital therapeutics, stringent regulatory scenario, and concerns over patient data privacy.

SELECT PLAYERS

Canary Health, Inc.; Dthera Sciences; Fitbit Health Solutions; Livongo Health, Inc.; Medtronic, Plc; Omada Health, Inc.; Propeller Health; Pear Therapeutics, Inc.; Proteus Digital Health, Inc.; WellDoc, Inc.

SEGMENTS

» Application (Preventive, Treatment/Care) » Sales Channel (B2C, B2B)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
Digital Therapeutics: An Introduction
Outlook
Leading Markets
Factors Impeding Growth
2. FOCUS ON SELECT PLAYERS
Canary Health, Inc. (USA)
Dthera Sciences (USA)
Fitbit Health Solutions (USA
Livongo Health, Inc. (USA)
Medtronic, Plc (Ireland)
Omada Health, Inc. (USA)
Propeller Health (USA)
Pear Therapeutics, Inc. (USA)
Proteus Digital Health, Inc. (USA)
WellDoc, Inc. (USA)
3. MARKET TRENDS & DRIVERS
Digital Therapeutics Continue to Attract Venture Capital Investments
TABLE: Total Venture Capital Funding and Number of Deals in Digital Health Space: 2011-2018
TABLE: Digital Health Funding by Segment (in US$ Million): 9M 2019
Startups Flock the Digital Therapeutics Market
Select Digital Therapeutics Startups
Digital Health Unicorn Startups
Table: Quarterly Investments by Digital Therapeutics Startups in US$ Million: Q1 2018 to Q2 2019
Pipeline Products Drive Growth Prospects
A Snapshot of Select DTx Pipeline Products
Pharma Majors Foray into Uncharted Territory
Pharmaceutical Companies Team Up with Payers to Seek Reimbursement
Growing Focus on Preventative Healthcare Widens Growth Opportunities
Overcoming the Stigma of Mental Health through Digital Therapeutics
Global Number of People Suffering from Mental Disorders (In Million)
Growing Prevalence of Chronic Diseases to Boost Market Growth
TABLE: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
TABLE: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025
Digital Therpeutics in Oncology
Proliferation of Smart Devices Bodes Well for Market Growth
TABLE: Smartphone Penetration (as a Proportion of Total Mobile Users) by Region for the Years 2018 and 2025
TABLE: United States Mobile Health Apps Market by Type (in %): 2018 & 2025
Growing Focus on Reducing Healthcare Costs Bolsters Market Growth
TABLE: Global Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, and 2022
Aging Population and their Vulnerability to Various Health Conditions: A Vital Growth Driver
TABLE: Global Population for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Treatment/Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Treatment/Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
USA Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Canada Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Japan Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
China Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Digital Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Europe Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
France Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Germany Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Italy Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
UK Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Rest of World Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
Total Companies Profiled: 56

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com